Posted On: 03/12/2015 11:54:57 PM
Post# of 30074
Seeing both Jason Napodano from Zacks and John Petrosino from JWP Incorporated listed as stock analysts, I think it's wise for shareholders to do some research on the analysts following Amarantus.
I've done a lot of research tonight and will report back soon if the analyst continues to have a negative outlook as that can be disconcerting to all the shareholders that have invested their money. I think we all want to know where stock analyst John Petrosino is coming from, his background and the years of experience stock analyst John Petrosino has, to make the professional call. It's surprising what I found out.
Hopefully the stock turns upwards and the stock analyst John Petrosino issues a buy rating soon.
Transcript of Amarantus BioScience Quarterly Update November 18, 2013
Participants
Gerald Commissiong – President & CEO
Dr. David Lowe, PhD – Independent Director
Dr. Adam Simon – Corporate Advisor
Analysts
Jason Napodano – Zacks
John Petrosino – JWP Incorporated
http://content.stockpr.com/amarantus/media/78...1a9e42.pdf
I've done a lot of research tonight and will report back soon if the analyst continues to have a negative outlook as that can be disconcerting to all the shareholders that have invested their money. I think we all want to know where stock analyst John Petrosino is coming from, his background and the years of experience stock analyst John Petrosino has, to make the professional call. It's surprising what I found out.
Hopefully the stock turns upwards and the stock analyst John Petrosino issues a buy rating soon.
Transcript of Amarantus BioScience Quarterly Update November 18, 2013
Participants
Gerald Commissiong – President & CEO
Dr. David Lowe, PhD – Independent Director
Dr. Adam Simon – Corporate Advisor
Analysts
Jason Napodano – Zacks
John Petrosino – JWP Incorporated
http://content.stockpr.com/amarantus/media/78...1a9e42.pdf
(0)
(0)
